Insmed Incorporated Company Profile & Data: stocks, market cap, financials, digital and more

                        
Company
Insmed IncorporatedHeadquarters: Bridgewater, 
                        NJ, United States
                    
Employees: 613
CEO: Mr. William H. Lewis J.D., M.B.A.

                                    NASDAQ: INSM
                                
                                            -1.06%
                                            
Market Cap$13.93 Billion

                        USD as of Jan. 1, 2025
                    
                            Market Cap History

Insmed Incorporated Categories

United States Healthcare Biotechnology
United States Healthcare United States Biotechnology

Insmed Incorporated market capitalization over time

Evolution of Insmed Incorporated market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Insmed Incorporated

Top Competitors by Market Capitalization

Industry: Biotechnology

Company	Market Cap (USD)
Novo Nordisk	$622.07 B
Vertex Pharmaceuticals Incorporated	$113.24 B
CSL Limited	$95.75 B
Regeneron Pharmaceuticals, Inc.	$76.33 B
Marinomed Biotech AG	$56.13 B

Sector:

Company	Market Cap (USD)
Lilly	$689.42 B
Novo Nordisk	$622.07 B
UnitedHealth Group	$487.54 B
Johnson & Johnson	$353.05 B
AbbVie	$301.60 B

Detailed Description

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date	Sept. 30, 2024
Revenue TTM	$343.0 M
EBITDA	$-695,056,000
Gross Profit TTM	$264.9 M
Profit Margin	-252.01%
Operating Margin	-212.73%
Quarterly Revenue Growth	18.20%